Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcutis Biotherapeutics (ARQT) Cost of Revenue (2022 - 2025)

Arcutis Biotherapeutics has reported Cost of Revenue over the past 4 years, most recently at $11.7 million for Q4 2025.

  • Quarterly results put Cost of Revenue at $11.7 million for Q4 2025, up 69.27% from a year ago — trailing twelve months through Dec 2025 was $36.7 million (up 91.84% YoY), and the annual figure for FY2025 was $36.7 million, up 91.84%.
  • Cost of Revenue for Q4 2025 was $11.7 million at Arcutis Biotherapeutics, up from $8.7 million in the prior quarter.
  • Over the last five years, Cost of Revenue for ARQT hit a ceiling of $11.7 million in Q4 2025 and a floor of $269000.0 in Q3 2022.
  • Median Cost of Revenue over the past 4 years was $3.4 million (2024), compared with a mean of $4.4 million.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 365.57% in 2024 and later surged 57.82% in 2025.
  • Arcutis Biotherapeutics' Cost of Revenue stood at $485000.0 in 2022, then soared by 363.09% to $2.2 million in 2023, then soared by 207.44% to $6.9 million in 2024, then soared by 69.27% to $11.7 million in 2025.
  • The last three reported values for Cost of Revenue were $11.7 million (Q4 2025), $8.7 million (Q3 2025), and $7.5 million (Q2 2025) per Business Quant data.